A systematic review of therapeutic strategies in gastroenteropancreatic grade 3 neuroendocrine tumors

BACKGROUND: Gastroenteropancreatic (GEP) neuroendocrine neoplasms with Ki-67 > 20% were subdivided in the most recent 2019 World Health Organization histopathological classification into grade 3 (G3) neuroendocrine tumors (NETs), described as well-differentiated tumors, and neuroendocrine carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Donadio, Mauro D., Brito, Ângelo B., Riechelmann, Rachel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Advances in Diagnosis and Treatment of Neuroendocrine Neoplasms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026121/
https://www.ncbi.nlm.nih.gov/pubmed/36950274
http://dx.doi.org/10.1177/17588359231156218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026121/
https://www.ncbi.nlm.nih.gov/pubmed/36950274
http://dx.doi.org/10.1177/17588359231156218

Ejemplares similares